CNSX:WRLD.U

Stock Analysis Report

Executive Summary

TRANSNATIONAL CANNABIS LTD, through its subsidiaries, engages in the cannabis business in Canada and internationally.


Snowflake Analysis

Imperfect balance sheet and overvalued.

Share Price & News

How has ICC International Cannabis's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: WRLD.U's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0%

WRLD.U

-2.4%

CA Pharmaceuticals

2.1%

CA Market


1 Year Return

-92.5%

WRLD.U

-74.4%

CA Pharmaceuticals

-21.2%

CA Market

Return vs Industry: WRLD.U underperformed the Canadian Pharmaceuticals industry which returned -48.6% over the past year.

Return vs Market: WRLD.U underperformed the Canadian Market which returned 10.4% over the past year.


Shareholder returns

WRLD.UIndustryMarket
7 Day0%-2.4%2.1%
30 Day-20.0%-12.9%-13.8%
90 Day-50.0%-33.7%-21.9%
1 Year-92.5%-92.5%-74.4%-74.4%-18.6%-21.2%
3 Year-71.4%-71.4%-26.9%-27.4%-11.0%-19.3%
5 Yearn/a188.5%188.5%1.6%-13.6%

Price Volatility Vs. Market

How volatile is ICC International Cannabis's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is ICC International Cannabis undervalued compared to its fair value and its price relative to the market?

0.13x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate WRLD.U's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate WRLD.U's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: WRLD.U is unprofitable, so we can't compare its PE Ratio to the Pharmaceuticals industry average.

PE vs Market: WRLD.U is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate WRLD.U's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: WRLD.U is good value based on its PB Ratio (0.1x) compared to the CA Pharmaceuticals industry average (1.4x).


Next Steps

Future Growth

How is ICC International Cannabis forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

65.6%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ICC International Cannabis has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has ICC International Cannabis performed over the past 5 years?

-95.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: WRLD.U is currently unprofitable.

Growing Profit Margin: WRLD.U is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: WRLD.U is unprofitable, and losses have increased over the past 5 years at a rate of -95.6% per year.

Accelerating Growth: Unable to compare WRLD.U's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: WRLD.U is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-11.3%).


Return on Equity

High ROE: WRLD.U has a negative Return on Equity (-85.92%), as it is currently unprofitable.


Next Steps

Financial Health

How is ICC International Cannabis's financial position?


Financial Position Analysis

Short Term Liabilities: WRLD.U's short term assets (CA$7.4M) exceed its short term liabilities (CA$2.8M).

Long Term Liabilities: WRLD.U's short term assets (CA$7.4M) do not cover its long term liabilities (CA$28.7M).


Debt to Equity History and Analysis

Debt Level: WRLD.U's debt to equity ratio (19.7%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if WRLD.U's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: WRLD.U has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if WRLD.U has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is ICC International Cannabis's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate WRLD.U's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate WRLD.U's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if WRLD.U's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if WRLD.U's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of WRLD.U's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.7yrs

Average management tenure


CEO

David Shpilt (40yo)

0.67

Tenure

Mr. David Shpilt serves as Chief Executive Officer and Director of Patient Services at Plants Not Pills. Mr. Shpilt serves as a Chief Executive Officer at ICC International Cannabis Corp. since joined it  ...


Leadership Team

NamePositionTenureCompensationOwnership
David Shpilt
Chief Executive Officer0.67yrno datano data
Peter Nguyen
CFO & Director0.50yrno datano data
Jonathan Beland
Vice President of Corporate Development0.67yrno datano data
Lauren Magda
Chief of Staff0.67yrno datano data
Catherine McClusky
Consultant5.67yrsCA$1.71kno data

0.7yrs

Average Tenure

Experienced Management: WRLD.U's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Peter Nguyen
CFO & Director0.50yrno datano data
Eugene Beukman
Independent Director1.67yrsno datano data
Stacy Quinney
Member of Advisory Board3.83yrsno datano data
Brendan Purdy
Independent Director1.5yrsno datano data
Julio Viskovich
Member of Advisory Board5.08yrsno datano data
Neill Franklin
Member of Advisory Board4.75yrsno datano data
Elaine Alec
Member of Advisory Boardno datano datano data
Michael Rigato
Member of Advisory Boardno datano datano data
Matthew Fish
Independent Director0.58yrno datano data
Matt Christopherson
Member of Advisory Board1yrno datano data

1.6yrs

Average Tenure

Experienced Board: WRLD.U's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 665.5%.


Top Shareholders

Company Information

TRANSNATIONAL CANNABIS LTD's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: TRANSNATIONAL CANNABIS LTD
  • Ticker: WRLD.U
  • Exchange: CNSX
  • Founded: 2006
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$14.122m
  • Shares outstanding: 706.11m
  • Website: https://www.intlcannabiscorp.com

Location

  • TRANSNATIONAL CANNABIS LTD
  • 789 West Pender Street
  • Suite 810
  • Vancouver
  • British Columbia
  • V6C 1H2
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
8K51DB (Deutsche Boerse AG)COM NPV (POST REV SPLT)DEEURNo data
WRLD.UCNSX (Canadian National Stock Exchange)YesCommon SharesCAUSDNov 2014
8K51DB (Deutsche Boerse AG)YesCommon SharesDEEURNov 2014
WLDC.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDNov 2014

Biography

ICC International Cannabis Corp., through its subsidiaries, engages in the cannabis business in Canada and internationally. It holds a license to cultivate, manufacture, supply, hold, import, export, and transport cannabis and derivative products; and engages in procuring and distributing medical cannabis products and cannabis derivatives. ICC International Cannabis Corp. has strategic partnerships with Green Tree International Inc., Auxly Cananbis Group Inc., Affinity Alpha Unit, Authentic Brands Group, and Biotii Technologies Corp. The company was formerly known as Kaneh Bosm BioTechnology Inc. and changed its name to ICC International Cannabis Corp. in September 2018. ICC International Cannabis Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/12/29 00:33
End of Day Share Price2019/12/20 00:00
Earnings2019/08/31
Annual Earnings2019/02/28


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.